Arvinas (ARVN) Other Working Capital Changes (2017 - 2026)

Arvinas (ARVN) recorded quarterly Other Working Capital Changes of -$15.6 million in Q1 2026, down 64.21% quarter-over-quarter from -$9.5 million in Q4 2025, and down 677.78% on a YoY basis from $2.7 million in Q1 2025.

Arvinas (ARVN) Other Working Capital Changes (2017 - 2026) Analysis & Trends

Arvinas' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$15.6 million for Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 677.78% year-over-year to -$15.6 million; the TTM figure through Mar 2026 stood at -$260.9 million (down 23618.18% YoY), while the FY2025 annual figure was -$242.6 million, down 12668.42% from the prior year.
  • Other Working Capital Changes was -$15.6 million for Q1 2026 at Arvinas, down from -$9.5 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $70.8 million in Q3 2023 to a low of -$214.0 million in Q2 2025.
  • Historically, Other Working Capital Changes has averaged -$15.3 million across 5 years, with a median of -$8.3 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes sank 1109.52% in 2022, then surged 5250.0% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$200000.0 in 2022, then soared by 5250.0% to $10.3 million in 2023, then plunged by 180.58% to -$8.3 million in 2024, then slipped by 14.46% to -$9.5 million in 2025, then tumbled by 64.21% to -$15.6 million in 2026.
  • The last three Other Working Capital Changes figures came in at -$15.6 million (Q1 2026), -$9.5 million (Q4 2025), and -$21.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arvinas 492.16 Mn -122.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.60 Mn
Mar 31, 2026 -15.60 Mn
Dec 31, 2025 -9.50 Mn
Dec 31, 2025 -9.50 Mn
Sep 30, 2025 -21.80 Mn
Sep 30, 2025 -21.80 Mn
Jun 30, 2025 -214.00 Mn
Jun 30, 2025 -214.00 Mn
Mar 31, 2025 2.70 Mn
Mar 31, 2025 2.70 Mn
Dec 31, 2024 -8.30 Mn
Dec 31, 2024 -8.30 Mn
Sep 30, 2024 -43.60 Mn
Sep 30, 2024 -43.60 Mn
Jun 30, 2024 48.10 Mn
Jun 30, 2024 48.10 Mn
Mar 31, 2024 1.90 Mn
Mar 31, 2024 1.90 Mn
Dec 31, 2023 10.30 Mn
Dec 31, 2023 10.30 Mn